产品简要
公司名称 :
Ventana
产品类型 :
抗体
产品名称 :
HER-2/neu
目录 :
790-2991
克隆性 :
单克隆
宿主 :
domestic rabbit
共轭标签 :
未共轭
克隆名称 :
4B5
反应物种 :
人类
应用 :
免疫印迹, 免疫组化, 免疫细胞化学, 免疫组化-石蜡切片
更多信息或购买 :
文章摘录数: 11
出版应用/物种/样本/稀释参考文献
  • 免疫组化-石蜡切片; 人类; 图 1d
Hryciuk B, Pęksa R, Bieńkowski M, Szymanowski B, Radecka B, Winnik K, et al. Expression of Female Sex Hormone Receptors, Connective Tissue Growth Factor and HER2 in Gallbladder Cancer. Sci Rep. 2020;10:1871 pubmed 出版商
  • 免疫细胞化学; 人类; 图 1c
Pietila M, Sahgal P, Peuhu E, Jäntti N, Paatero I, Närvä E, et al. SORLA regulates endosomal trafficking and oncogenic fitness of HER2. Nat Commun. 2019;10:2340 pubmed 出版商
  • 免疫组化-石蜡切片; 人类; 表 s1
Doebar S, Sieuwerts A, de Weerd V, Stoop H, Martens J, van Deurzen C. Gene Expression Differences between Ductal Carcinoma in Situ with and without Progression to Invasive Breast Cancer. Am J Pathol. 2017;187:1648-1655 pubmed 出版商
  • 免疫组化-石蜡切片; 人类; 图 1g
  • 免疫印迹; 人类; 1:10; 图 1c
Qi L, Zhou L, Lu M, Yuan K, Li Z, Wu G, et al. Development of a highly specific HER2 monoclonal antibody for immunohistochemistry using protein microarray chips. Biochem Biophys Res Commun. 2017;484:248-254 pubmed 出版商
  • 免疫组化-石蜡切片; 人类; 表 3
Leo F, Bartels S, Mägel L, Framke T, Büsche G, Jonigk D, et al. Prognostic factors in the myoepithelial-like spindle cell type of metaplastic breast cancer. Virchows Arch. 2016;469:191-201 pubmed 出版商
  • 免疫组化; 人类
Song M, Park Y, Song H, Park S, Ahn J, Choi K, et al. Prognosis of Pregnancy-Associated Gastric Cancer: An Age-, Sex-, and Stage-Matched Case-Control Study. Gut Liver. 2016;10:731-8 pubmed 出版商
  • 免疫组化; 人类
Gómez R, Ossa C, Montoya M, Echeverri C, Ángel G, Ascuntar J, et al. Impact of immunohistochemistry-based molecular subtype on chemosensitivity and survival in Hispanic breast cancer patients following neoadjuvant chemotherapy. Ecancermedicalscience. 2015;9:562 pubmed 出版商
  • 免疫组化-石蜡切片; 人类; 图 6c
Thomas G, Chardès T, Gaborit N, Mollevi C, Leconet W, Robert B, et al. HER3 as biomarker and therapeutic target in pancreatic cancer: new insights in pertuzumab therapy in preclinical models. Oncotarget. 2014;5:7138-48 pubmed
Pinder S, Campbell A, Bartlett J, Marshall A, Allen D, Falzon M, et al. Discrepancies in central review re-testing of patients with ER-positive and HER2-negative breast cancer in the OPTIMA prelim randomised clinical trial. Br J Cancer. 2017;116:859-863 pubmed 出版商
Catalano O, Horn G, Signore A, Iannace C, Lepore M, Vangel M, et al. PET/MR in invasive ductal breast cancer: correlation between imaging markers and histological phenotype. Br J Cancer. 2017;116:893-902 pubmed 出版商
Rikhi R, Wilson E, Déas O, Svalina M, Bial J, Mansoor A, et al. Murine model of hepatic breast cancer. Biochem Biophys Rep. 2016;8:1-5 pubmed 出版商
公司信息